XFRA CAPITAL ADJUSTMENT INFORMATION

XFRA CAPITAL ADJUSTMENT INFORMATION - 24.12.2024

Das Instrument US09063M2052 BIONOMICS ADR/1/180 EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024
The instrument US09063M2052 BIONOMICS ADR/1/180 EQUITY is traded cum capital adjustment on 24.12.2024 and ex capital adjustment on 27.12.2024

Das Instrument FR00140085W6 MRM SA INH. EO 20 EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024
The instrument FR00140085W6 MRM SA INH. EO 20 EQUITY is traded cum capital adjustment on 24.12.2024 and ex capital adjustment on 27.12.2024

Das Instrument FR0000075392 ORAPI S.A. INH. EO 1 EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024

The instrument FR0000075392 ORAPI S.A. INH. EO 1 EQUITY is traded cum capital adjustment on 24.12.2024 and ex capital adjustment on 27.12.2024

Das Instrument JUA JP3027680002 JAPAN REAL EST.INVESTM. EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024
The instrument JUA JP3027680002 JAPAN REAL EST.INVESTM. EQUITY is traded cum capital adjustment on 24.12.2024 and ex capital adjustment on 27.12.2024

Das Instrument UN4 JP3951600000 UNICHARM CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024
The instrument UN4 JP3951600000 UNICHARM CORP. EQUITY is traded cum capital adjustment on 24.12.2024 and ex capital adjustment on 27.12.2024

Das Instrument KEI JP3278600006 KEISEI EL. RWY EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024
The instrument KEI JP3278600006 KEISEI EL. RWY EQUITY is traded cum capital adjustment on 24.12.2024 and ex capital adjustment on 27.12.2024

Das Instrument AS0 BE0974289218 EUROPEAN MEDICAL SOLU. EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024
The instrument AS0 BE0974289218 EUROPEAN MEDICAL SOLU. EQUITY is traded cum capital adjustment on 24.12.2024 and ex capital adjustment on 27.12.2024

Das Instrument 82T0 NO0012958539 AEGA ASA NK 0,50 EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024
The instrument 82T0 NO0012958539 AEGA ASA NK 0,50 EQUITY is traded cum capital adjustment on 24.12.2024 and ex capital adjustment on 27.12.2024

Die USA haben fertig! 5 Aktien für den China-Boom

Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!

Hier klicken

Zeit	Aktuelle Nachrichten
14.04.	EUROPEAN MEDICAL SOLUTIONS (ex DMS IMAGING): EMS GROUP: ANNUAL RESULTS 2024 - SUSTAINED GROWTH AND STRONG IMPROVEMENT IN OPERATIONAL PROFITABILITY		2024 Revenue with Continuous Growth: €45.1 million, up 11% Significant Improvement in EBITDA: +69% Significant Reduction in Operational Costs and overhead costs from the 2nd half of the year April... ► Artikel lesen
30.12.24	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.12.2024		The following instruments on XETRA do have their first trading 30.12.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.12.2024 Aktien 1 JP3407800006 Sumitomo Densetsu Co.... ► Artikel lesen

Zeit

Aktuelle Nachrichten

14.04.

EUROPEAN MEDICAL SOLUTIONS (ex DMS IMAGING): EMS GROUP: ANNUAL RESULTS 2024 - SUSTAINED GROWTH AND STRONG IMPROVEMENT IN OPERATIONAL PROFITABILITY

2024 Revenue with Continuous Growth: €45.1 million, up 11% Significant Improvement in EBITDA: +69% Significant Reduction in Operational Costs and overhead costs from the 2nd half of the year April...
► Artikel lesen

30.12.24

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.12.2024

The following instruments on XETRA do have their first trading 30.12.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.12.2024 Aktien 1 JP3407800006 Sumitomo Densetsu Co....
► Artikel lesen

Zeit	Aktuelle Nachrichten
15.05.	JRE-Chef Jagdfeld will bis € 100 Mio. in den nächsten Jahren investieren
28.03.	Dividendenbekanntmachungen (28.03.2025)	Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen
24.12.24	XFRA CAPITAL ADJUSTMENT INFORMATION - 24.12.2024	Das Instrument US09063M2052 BIONOMICS ADR/1/180 EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024 The instrument US09063M2052 BIONOMICS ADR/1/180 EQUITY... ► Artikel lesen
27.09.24	Dividendenbekanntmachungen (27.09.2024)	Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen

Zeit

Aktuelle Nachrichten

15.05.

JRE-Chef Jagdfeld will bis € 100 Mio. in den nächsten Jahren investieren

28.03.

Dividendenbekanntmachungen (28.03.2025)

Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20...
► Artikel lesen

24.12.24

XFRA CAPITAL ADJUSTMENT INFORMATION - 24.12.2024

27.09.24

Dividendenbekanntmachungen (27.09.2024)

Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7...
► Artikel lesen

Zeit	Aktuelle Nachrichten
16.06.	Palliser Capital: Both ISS and Glass Lewis Recommend Shareholders Vote AGAINST Keisei President Toshiya Kobayashi, Endorsing Palliser's Call for Governance Reform	Unanimous ISS and Glass Lewis recommendation to vote AGAINST current President Kobayashi to hold him accountable for severe long-standing failures in governance and performance ISS further... ► Artikel lesen
05.06.	Palliser Capital: Palliser to Vote Against President Kobayashi and Other Directors at Forthcoming AGM to Break Keisei's Destructive Cycle of Inaction and Management Entrenchment	Palliser believes full Board culpable but six Board nominees, including President Kobayashi and the outside members of the Nomination Compensation Committee, should be immediately opposed by... ► Artikel lesen
08.05.	Palliser Capital: Palliser Recognizes Progress in Nomination Process for Independent Director Candidates at Keisei Electric Railway	Palliser Capital ("Palliser") today published a letter regarding progress of the nomination and appointment process for the new Palliser-proposed independent outside director candidates to help reconfigure... ► Artikel lesen
24.04.	Palliser Capital Calls for Immediate Action in Keisei's Forthcoming D2 Plan and Board Reconfiguration with Palliser-Proposed Candidates at its AGM	Palliser Capital doubles Keisei shareholding since 2024 AGM now over 4.5% Calls to restore market confidence with decisive D2 Plan and re-dimensioning of Board with nomination of four Palliser-proposed... ► Artikel lesen
28.03.	Dividendenbekanntmachungen (28.03.2025)	Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen

Zeit

Aktuelle Nachrichten

16.06.

Palliser Capital: Both ISS and Glass Lewis Recommend Shareholders Vote AGAINST Keisei President Toshiya Kobayashi, Endorsing Palliser's Call for Governance Reform

Unanimous ISS and Glass Lewis recommendation to vote AGAINST current President Kobayashi to hold him accountable for severe long-standing failures in governance and performance ISS further...
► Artikel lesen

05.06.

Palliser Capital: Palliser to Vote Against President Kobayashi and Other Directors at Forthcoming AGM to Break Keisei's Destructive Cycle of Inaction and Management Entrenchment

Palliser believes full Board culpable but six Board nominees, including President Kobayashi and the outside members of the Nomination Compensation Committee, should be immediately opposed by...
► Artikel lesen

08.05.

Palliser Capital: Palliser Recognizes Progress in Nomination Process for Independent Director Candidates at Keisei Electric Railway

Palliser Capital ("Palliser") today published a letter regarding progress of the nomination and appointment process for the new Palliser-proposed independent outside director candidates to help reconfigure...
► Artikel lesen

24.04.

Palliser Capital Calls for Immediate Action in Keisei's Forthcoming D2 Plan and Board Reconfiguration with Palliser-Proposed Candidates at its AGM

Palliser Capital doubles Keisei shareholding since 2024 AGM now over 4.5% Calls to restore market confidence with decisive D2 Plan and re-dimensioning of Board with nomination of four Palliser-proposed...
► Artikel lesen

28.03.

Dividendenbekanntmachungen (28.03.2025)

Zeit	Aktuelle Nachrichten
27.05.	Neuphoria Therapeutics, Inc.: Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
20.05.	Neuphoria Therapeutics, Inc.: Neuphoria Provides First Quarter 2025 Business Updates	Cash runway into Q3 2026AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025a7 nicotinic acetylcholine receptor PAM MK-1167 partnered with... ► Artikel lesen
20.05.	Neuphoria Therapeutics Inc. - 8-K, Current Report
20.05.	Neuphoria Therapeutics Inc. - 10-Q, Quarterly Report
03.03.	Neuphoria Therapeutics, Inc.: Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

Zeit

Aktuelle Nachrichten

27.05.

Neuphoria Therapeutics, Inc.: Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting

20.05.

Neuphoria Therapeutics, Inc.: Neuphoria Provides First Quarter 2025 Business Updates

Cash runway into Q3 2026AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025a7 nicotinic acetylcholine receptor PAM MK-1167 partnered with...
► Artikel lesen

20.05.

Neuphoria Therapeutics Inc. - 8-K, Current Report

20.05.

Neuphoria Therapeutics Inc. - 10-Q, Quarterly Report

03.03.

Neuphoria Therapeutics, Inc.: Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

Zeit	Aktuelle Nachrichten
Do	Nordic Financials ASA - Subscription by primary insiders in the rights issue
Mi	Nordic Financials ASA - Mandatory notification of trade
Di	Nordic Financials ASA: Mandatory Notification of Trading by Primary Insiders
Di	Nordic Financials ASA: Shareholding disclosure
Di	Nordic Financials ASA - Last day of trading in subscription rights today

Zeit

Aktuelle Nachrichten

Nordic Financials ASA - Subscription by primary insiders in the rights issue

Nordic Financials ASA - Mandatory notification of trade

Nordic Financials ASA: Mandatory Notification of Trading by Primary Insiders

Nordic Financials ASA: Shareholding disclosure

Nordic Financials ASA - Last day of trading in subscription rights today

Zeit	Aktuelle Nachrichten
24.12.24	XFRA CAPITAL ADJUSTMENT INFORMATION - 24.12.2024		Das Instrument US09063M2052 BIONOMICS ADR/1/180 EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024 The instrument US09063M2052 BIONOMICS ADR/1/180 EQUITY... ► Artikel lesen

Zeit

Aktuelle Nachrichten

24.12.24

XFRA CAPITAL ADJUSTMENT INFORMATION - 24.12.2024

Zeit	Aktuelle Nachrichten
19.06.	Unicharm and Toyota Tsusho to set up sanitary goods joint venture in Kenya
19.06.	Unicharm, Toyota Tsusho to Set Up Sanitary Goods JV in Kenya
09.05.	Unicharm Corporation reports Q1 results
24.12.24	XFRA CAPITAL ADJUSTMENT INFORMATION - 24.12.2024	Das Instrument US09063M2052 BIONOMICS ADR/1/180 EQUITY wird cum Kapitalmassnahme gehandelt am 24.12.2024 und ex Kapitalmassnahme am 27.12.2024 The instrument US09063M2052 BIONOMICS ADR/1/180 EQUITY... ► Artikel lesen

Zeit

Aktuelle Nachrichten

19.06.

Unicharm and Toyota Tsusho to set up sanitary goods joint venture in Kenya

19.06.

Unicharm, Toyota Tsusho to Set Up Sanitary Goods JV in Kenya

09.05.

Unicharm Corporation reports Q1 results

24.12.24

XFRA CAPITAL ADJUSTMENT INFORMATION - 24.12.2024

Unternehmen / Aktien	Kurs	%
EUROPEAN MEDICAL SOLUTIONS SA	4,233	0,00 %
JAPAN REAL ESTATE INVESTMENT CORPORATION	690,00	0,00 %
KEISEI ELECTRIC RAILWAY CO LTD	8,050	0,00 %
NEUPHORIA THERAPEUTICS INC	6,820	0,00 %
NORDIC FINANCIALS ASA	0,002	0,00 %
ORAPI SA	6,100	0,00 %
UNICHARM CORPORATION	6,150	-2,38 %

Unternehmen / Aktien

Kurs

EUROPEAN MEDICAL SOLUTIONS SA

4,233

0,00 %

JAPAN REAL ESTATE INVESTMENT CORPORATION

690,00

0,00 %

KEISEI ELECTRIC RAILWAY CO LTD

8,050

0,00 %

NEUPHORIA THERAPEUTICS INC